NEW YORK--(BUSINESS WIRE)-- IFF (NYSE: IFF) today announced that it has entered into a definitive agreement to sell its Pharma Solutions business unit to French leader of plant-based ingredients ...

Improving the World of Dietary Supplements with a Breadth of Proven Brands. "We are excited to highlight vivid examples of how our high-quality functional ingredients and technical expertise help our ...

Global Leading Excipient Supplier to Highlight Innovations in Oral Disintegrating Tablets, Controlled Release Formulations, and Low-Nitrite Solutions TOKYO--(BUSINESS WIRE)-- IFF (NYSE:IFF) Pharma ...

NEW YORK — IFF and Roquette have entered into a definitive agreement under which New York-based IFF will sell its Pharma Solutions business unit to Roquette, La Madeliene, France, for an enterprise ...

Low Nitrite METHOCEL™ HPMC reduces the potential for nitrosamine formation and provides consistent results in finished dosages. NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) Pharma Solutions, a global ...

Roquette has agreed to acquire IFF Pharma Solutions, a producer of ingredients for oral dosage solutions, for an enterprise value of up to $2.85 billion. IFF is a leading producer of excipients for ...

International Flavors & Fragrances Inc (NYSE:IFF) said it has entered into a definitive agreement to sell its Pharma Solutions business unit to French plant-based ingredients Roquette for an ...

Recognized for brand leadership with its "Timing is Everything" controlled release platform for oral drug delivery. NEW YORK, Jan. 14, 2025 /PRNewswire/ -- IFF (NYSE: IFF) Pharma Solutions, a global ...

NEW YORK, Oct. 14, 2024 /PRNewswire/ -- IFF (NYSE:IFF) Pharma Solutions will demonstrate the critical role of excipients in drug formulation by showcasing breakthrough research at AAPS 2024 PharmSci ...

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) Pharma Solutions is excited to announce its participation at Vitafoods™ Europe 2025, the premier global nutraceutical event. The team will showcase its ...